Gries Financial’s Gilead Sciences GILD Stock Holding History

Gries Financial’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-7,776	Closed	-$645K	–	160
2023 Q1	$645K	Sell	7,776 -41,184	-84%	-$3.41M	0.19%	99
2022 Q4	$4.2M	Buy	48,960 +15,489	+46%	+$1.23M	1.4%	13
2022 Q3	$2.06M	Buy	33,471 +1,382	+4%	+$87.1K	0.87%	26
2022 Q2	$1.98M	Buy	32,089 +623	+2%	+$38.6K	0.94%	28
2022 Q1	$1.87M	Buy	31,466 +10,198	+48%	+$652K	0.69%	41
2021 Q4	$1.54M	Sell	21,268 -22,003	-51%	-$1.52M	0.63%	40
2021 Q3	$3.02M	Sell	43,271 -4,722	-10%	-$332K	0.95%	23
2021 Q2	$3.32M	Buy	47,993 +18,676	+64%	+$1.25M	1.07%	17
2021 Q1	$2.02M	Buy	+29,317	New	+$1.89M	0.64%	51

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Gries Financial's GILD Position: Q2 2023 in Review

Gries Financial sold out of Gilead Sciences (GILD) in Q2 2023, closing a stake of 7,776 shares — an estimated $645K sold.

Gries Financial first reported a position in GILD in Q1 2021 and held it in 9 quarters. The position peaked at $4.2M in Q4 2022. 1,702 funds tracked by Wall St. Rank hold GILD as of Q2 2023.

Gries Financial reported no remaining Gilead Sciences position as of Q2 2023 after selling out during the quarter.
Gries Financial sold 7,776 Gilead Sciences shares in Q2 2023, an estimated $645K.
Gries Financial first reported a position in Gilead Sciences in Q1 2021 and held it in 9 quarters.
Gries Financial's Gilead Sciences position peaked at $4.2M in Q4 2022.
1,702 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2023.

Based on Gries Financial's 13F filing for Q2 2023, filed 15 Aug 2023.